Dr. Daniel Yazdi, MD

  • Sylmar, CA
  • Internist
NPI1417485434PAC ID0941614275
Part D claims, 2024
105
Publications
2
Hospital affiliations
2
Industry payments
$996
State licenses
2
Practice address
14445 Olive View Drive, Sylmar, CA 91342
Practice phone
Call (818) 364-1555
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Olive View-UCLA Medical Center

Hospital · Sylmar, California

See all 3 affiliations

Find Dr. Yazdi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel Yazdi is an internist in Sylmar, California

Dr. Yazdi practices at Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles.

Dr. Yazdi's NPI, 1417485434, was assigned on June 3, 2017. Dr. Yazdi graduated from David Geffen School of Medicine at UCLA in 2017. Dr. Yazdi holds California license A169370.

NPI and contact details
Medicare PAC ID
0941614275
NPI enumeration date
June 3, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(818) 364-1555
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daniel Yazdi practices at Olive View-UCLA Medical Center in Sylmar, California

Dr. Yazdi's primary practice is Olive View-UCLA Medical Center, at 14445 Olive View Drive, Sylmar, CA 91342 in Los Angeles County. The practice phone is (818) 364-1555.

Source: Dmand AI Affiliation Data

Dr. Daniel Yazdi is affiliated with 3 sites of care

Dr. Yazdi's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dr. Yazdi is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Yazdi to 1 more physician office, named with a free account. Dr. Yazdi's employer is on file too: a hospital.

See all 3 affiliations for Dr. Yazdi

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Daniel Yazdi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazdi practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Olive View-UCLA Medical CenterAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Yazdi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across County of Los Angeles and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel Yazdi is one of 16,751 internists in California

Internal medicine is Dr. Yazdi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yazdi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Yazdi's licenses on file in 2 states: California and Massachusetts.

Specialties and state licenses

  • Internal medicine, CaliforniaPrimaryLicense A169370 · 2020 to 2026 · taxonomy 207R00000X
  • Massachusetts licenseLicense 271540 · 2017 to 2020

Internists near Dr. Yazdi

Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel Yazdi's patients have a median age of 33

Across all payers, Dmand AI patient panel data puts Dr. Yazdi's median patient age at 33, with 100% women.

Dr. Yazdi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 33

Patient panel by sex, all payers

  • Women100%
  • Men0%

Source: Dmand AI Patient Panel Data

Dr. Daniel Yazdi wrote 105 Medicare Part D claims in 2024

In 2024, Dr. Yazdi wrote 105 Medicare Part D claims for 18 patients. 66% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $25,527 in total drug cost. In 2020, CMS named 103 claims across 7 drugs.

Part D claims, 2024105
Drugs named by CMS4
Total drug cost$25,527
Part D patients18

Dr. Yazdi's Part D claims by kind of drug, 2024

  • Generic69 claims66%
  • Brand-name36 claims34%

Dr. Yazdi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2024

  • 2020
  • 2024
Claims for drugs CMS names
2020: 1032024: 5547%

Drugs named by CMS: 4 in 2024, 7 in 2020.

See all prescribing by Dr. Yazdi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daniel Yazdi offers telehealth to Medicare patients

Dr. Yazdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yazdi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find internists like Dr. Yazdi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel Yazdi has 2 publications on record

Dmand AI links 2 papers to Dr. Yazdi in 2016. Dr. Yazdi's most frequent co-author is Justin David Sharim, MD.

Papers2

Dr. Yazdi's most frequent co-authors

Recent publications by Dr. Yazdi

See all 2 publications and co-authors

See who Dr. Yazdi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yazdi works with, so you can find a warm path to the right internists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daniel Yazdi received $996 in industry payments from 2022 to 2025

CMS Open Payments shows 16 general payments to Dr. Yazdi from 11 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 75% of the total. Abbott Laboratories paid the most, $246.

General payments to Dr. Yazdi by program year, 2022 to 2025

General payments to Dr. Yazdi by kind, 2022 to 2025

$996in total
  • Food and beverage$74975%
  • Education$24625%

Companies that paid Dr. Yazdi the most, 2022 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Yazdi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daniel Yazdi graduated from David Geffen School of Medicine at UCLA

Dr. Yazdi graduated from David Geffen School of Medicine at UCLA in 2017.

  1. Medical schoolDavid Geffen School of Medicine at UCLA
  2. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Daniel Yazdi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel Yazdi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel Yazdi's NPI number?

Dr. Daniel Yazdi's NPI number is 1417485434. It was assigned on June 3, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel Yazdi?

Dr. Daniel Yazdi is an internist in Sylmar, California. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).

Where does Dr. Daniel Yazdi practice?

Dr. Yazdi practices at 14445 Olive View Drive, Sylmar, CA 91342. Dr. Yazdi's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dmand AI also links Dr. Yazdi to 1 physician office.

What is Dr. Daniel Yazdi's office phone number?

The practice phone on file for Dr. Yazdi is (818) 364-1555.

What is Dr. Daniel Yazdi's medical license number?

Dr. Yazdi holds California license A169370, one of the licenses on file in 2 states.

Which states has Dr. Daniel Yazdi been licensed in?

Dmand AI has state licenses on file for Dr. Yazdi in California (2020 to 2026) and Massachusetts (2017 to 2020).

Which hospitals is Dr. Daniel Yazdi affiliated with?

Dr. Yazdi practices at Olive View-UCLA Medical Center in Sylmar, California. Dr. Yazdi is also affiliated with Cedars-Sinai Medical Center.

Does Dr. Daniel Yazdi accept Medicare?

Yes. CMS lists Dr. Yazdi as accepting Medicare assignment.

Does Dr. Daniel Yazdi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Yazdi as offering telehealth services.

Is Dr. Daniel Yazdi board certified?

Yes. Dr. Yazdi is board certified in internal medicine by the American Board of Internal Medicine.

Show 6 more questionsShow fewer questions

Where did Dr. Daniel Yazdi go to medical school?

Dr. Yazdi graduated from David Geffen School of Medicine at UCLA in 2017.

What drugs does Dr. Daniel Yazdi prescribe most?

In 2024 Medicare Part D data, Dr. Yazdi's most prescribed drugs by claims were Jardiance, Entresto and Metoprolol Succinate.

Has Dr. Daniel Yazdi received payments from drug or device companies?

CMS Open Payments shows $996 in general payments to Dr. Yazdi from 11 companies from 2022 to 2025. The largest total came from Abbott Laboratories.

How long has Dr. Daniel Yazdi been practicing?

Dr. Yazdi graduated from medical school in 2017, 9 years ago.

Does Dr. Daniel Yazdi do research?

Dmand AI links 2 publications to Dr. Yazdi.

Who does Dr. Daniel Yazdi publish with?

Dr. Yazdi's most frequent co-authors are Justin David Sharim, MD (1 shared paper).

Selling to internal medicine practices?

See internists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)